Biosensors International Group Ltd – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Biosensors International Group Ltd (Biosensors) is a medical device company that develops and markets critical care catheter systems and related devices. The company develops products using its proprietary limus technology. Its major cardiovascular products include drug coated stents, drug-eluting stents, bare metal stents and angioplasty catheters used for the treatment of coronary artery disease. The company’s endovascular products include solutions for below the knee and superficial femoral artery interventions. Biosensors’s products are used during heart surgery and intensive care procedures. The company markets products directly and also through a network of distributors across the Americas, Europe, the Middle East, Asia and Africa. Biosensors is headquartered in Singapore.

Biosensors International Group Ltd Key Recent Developments

Aug 13,2018: Biotage: New findings presented at ASMS 2018
Feb 13,2018: Biosensors International Group: Finally-an Easy Urine Sample Preparation for LC/MS Analysis

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.